The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter

Journal of Neurochemistry

Volumn 107, Issue 4, 2008, Pages 1083-1090

  Yin, Zhaobao ^a   Jiang, Haiyan ^a   Syversen, Tore ^b   Rocha, João B T ^c   Farina, Marcelo ^d   Aschner, Michael ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Amino acid transport; L type large neutral amino acid transporter; Methylmercury; Neurotoxicity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINO ACID TRANSPORTER; CYSTEINE; L TYPE LARGE NEUTRAL AMINO ACID TRANSPORTER 1; LACTATE DEHYDROGENASE; METHIONINE; METHYLMERCURY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; MEMBRANE TRANSPORT; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

EID: 84984577326     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05683.x     Document Type: Article

References (56)

1. Aschner M. (1989) Brain, kidney and liver 203 Hg-methyl mercury uptake in the rat: relationship to the neutral amino acid carrier. Pharmacol. Toxicol. 65, 17 20.
2. Aschner M. Clarkson T. W. (1988) Uptake of methylmercury in the rat brain: effects of amino acids. Brain Res. 462, 31 39.
3. Aschner M. Clarkson T. W. (1989) Methyl mercury uptake across bovine brain capillary endothelial cells in vitro: the role of amino acids. Pharmacol. Toxicol. 64, 293 297.
4. Aschner M., Eberle N. B., Goderie S. Kimelberg H. K. (1990) Methylmercury uptake in rat primary astrocyte cultures: the role of the neutral amino acid transport system. Brain Res. 521, 221 228.
5. ATSDR: Agency for Toxic Substance and Disease Registry 2003) Toxicological Profile for Mercury. U.S. Department of Health and Humans Services, Public Health Services, Centers for Disease Control, Atlanta, GA.
6. Babu E., Kanai Y., Chairoungdua A. et al. (2003) Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J. Biol. Chem. 278, 43838 43845.
7. Bakir F., Damluji S. F., Amin-Zaki L. et al. (1973) Methylmercury poisoning in Iraq. Science 181, 230 241.
8. Ballatori N. (2002) Transport of toxic metals by molecular mimicry. Environ. Health Perspect. 110, 689 694.
9. Boado R. J., Li J. Y., Nagaya M., Zhang C. Pardridge W. M. (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc. Natl Acad. Sci. USA 96, 12079 12084.
10. Boado R. J., Li J. Y. Pardridge W. M. (2004) Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein. Pediatr. Res. 55, 557 560.
11. Bodoy S., Martín L., Zorzano A., Palacín M., Estévez R. Bertran J. (2005) Identification of LAT4, a novel amino acid transporter with system L activity. J. Biol. Chem. 280, 12002 12011.
12. Bridges C. C. Zalups R. K. (2005) Molecular and ionic mimicry and the transport of toxic metals. Toxicol. Appl. Pharmacol. 204, 274 308.
13. Carty A. J. Malone S. J. (1979) The chemistry of mercury in biological systems, in The Biogeochemistry of Mercury in the Environment, vol. 3 (Nriagu J. O., ed. pp. 433 479. Elsevier/North-Holland Biomedical Press, Amsterdam.
14. Christensen H. N. (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70, 43 77.
15. Clarkson T. W. (1972) The biological properties and distribution of mercury. Biochem. J. 130, 61 63.
16. Clarkson T. W. (1993) Molecular and ionic mimicry of toxic metals. Annu. Rev. Pharmacol. Toxicol. 33, 545 571.
17. Costa L. G., Aschner M., Vitalone A., Syversen T. Soldin O. P. (2004) Developmental neuropathology of environmental agents. Annu. Rev. Pharmacol. Toxicol. 44, 87 110.
18. Davidson P. W., Reeves J. S., Myers G. J. et al. (2008) Association between prenatal exposure to methylmercury and visuospatial ability at 10.7 years in the Seychelles child development study. Neurotoxicology 29, 453 459.
19. Debes F., Budtz-Jørgensen E., Weihe P., White R. F. Grandjean P. (2006) Impact of prenatal methylmercury exposure on neurobehavioural function at age 14 years. Neurotoxicol. Teratol. 28, 363 375.
20. Duelli R., Enerson B. E., Gerhart D. Z. Drewes L. R. (2000) Expression of large amino acid transporter LAT1 in rat brain endothelium. J. Cereb. Blood Flow Metab. 20, 1557 1562.
21. Ekino S., Susa M., Ninomiya T., Imamura K. Kitamura T. (2007) Minamata disease revisited: an update on the acute and chronic manifestations of methyl mercury poisoning. J. Neurol. Sci. 262, 131 144.
22. Falluel-Morel A., Sokolowski K., Sisti H. M., Zhou X., Shors T. J. Dicicco-Bloom E. (2007) Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J. Neurochem. 103, 1968 1981.
23. Gage F. H. (2000) Mammalian neural stem cells. Science 287, 1433 1438.
24. Grandjean P. (2007) Methylmercury toxicity and functional programming. Reprod. Toxicol. 23, 414 420.
25. Hirayama K. (1980) Effect of amino acids on brain uptake of methyl mercury. Toxicol. Appl. Pharmacol. 55, 318 323.
26. Hughes W. L. (1957) A physicochemical rationale for the biological activity of mercury and its compounds. Ann. NY Acad. Sci. 65, 454 460.
27. Kageyama T., Imura T., Matsuo A., Minato N. Shimohama S. (2000) Distribution of the 4F2 light chain, LAT1, in the mouse brain. Neuroreport 11, 3663 3666.
28. Kajiwara Y., Yasutake A., Adachi T. Hirayama K. (1996) Methylmercury transport across the placenta via neutral amino acid carrier. Arch. Toxicol. 70, 310 314.
29. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E. Endou H. (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273, 23629 23632.
30. Kerper L. E., Ballatori N. Clarkson T. W. (1992) Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am. J. Physiol. 262, R761 R765.
31. Killian D. M. Chikhale P. J. (2001) Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci. Lett. 306, 1 4.
32. Kühne A., Kaiser R., Schirmer M. et al. (2007) Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. Pharmacogenet. Genomics. 17, 505 517.
33. Langlois A., Lee S., Kim D. S., Dirks P. B. Rutka J. T. (2002) p16(ink4a) and retinoic acid modulate rhoA and GFAP expression during induction of a stellate phenotype in U343 MG-A astrocytoma cells. Glia 40, 85 94.
34. Manfroi C. B., Schwalm F. D., Cereser V. et al. (2004) Maternal milk as methylmercury source for suckling mice: neurotoxic effects involved with the cerebellar glutamatergic system. Toxicol. Sci. 81, 172 178.
35. Mastroberardino L., Spindler B., Pfeiffer R., Skelly P. J., Loffing J. C. B., Shoemaker C. B. Verrey F. (1998) Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395, 288 291.
36. Matsuo H., Tsukada S., Nakata T. et al. (2000) Expression of a system L neutral amino acid transporter at the blood-brain barrier. Neuroreport 11, 3507 3511.
37. Meier C., Ristic Z., Klauser S. Verrey F. (2002) Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 21, 580 589.
38. Mokrzan E. M., Kerper L. E., Ballatori N. Clarkson T. W. (1995) Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L. J. Pharmacol. Exp. Ther. 272, 1277 1284.
39. Myers G. J., Davidson P. W. Shamlaye C. F. (1998) A review of methylmercury and child development. Neurotoxicology 19, 313 328.
40. Nakamura E., Sato M., Yang H. et al. (1999) 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J. Biol. Chem. 274, 3009 3016.
41. Ninomiya T., Ohmori H., Hashimoto K., Tsuruta K. Ekino S. (1995) Expansion of methylmercury poisoning outside of Minamata: an epidemiological study on chronic methylmercury poisoning outside of Minamata. Environ. Res. 70, 47 50.
42. Oldendorf W. H. (1971) Brain uptake of radiolabeled amino acid, amines, and hexoses after arterial injection. Am. J. Physiol. 221, 1629 1639.
43. Onishchenko N., Tamm C., Vahter M., Hokfelt T., Johnson J., Johnson D. Ceccatelli S. (2007) Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice. Toxicol. Sci. 97, 428 437.
44. Oxender D. L. Christensen H. N. (1963) Evidence for two types of mediation of neutral and amino acid transport in Ehrlich cells. Nature 197, 765 767.
45. Pineda M., Femández E., Torrents D., Estévez R., López C., Camps M., Lloberas J., Zorzano A. Palacin M. (1999) Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J. Biol. Chem. 274, 19738 19744.
46. Prasad P. D., Wang H., Huang W., Kekuda R., Rajan D. P., Leibach F. H. Ganapathy V. (1999) Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem. Biophys. Res. Commun. 255, 283 288.
47. Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H. Kanai Y. (1999) Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J. Biol. Chem. 274, 19745 19751.
48. Simmons-Willis T. A., Koh A. S., Clarkson T. W. Ballatori N. (2002) Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Bioechem. J. 367, 239 246.
49. Takeuchi T. (1972) Biological reactions and pathological changes in human beings and animals caused by organic mercury contamination, in Environmental Mercury Contamination (Hartung R. Dinman B. D., eds pp. 247 289. Ann Arbor Science, Ann Arbor.
50. Tamm C., Duckworth J., Hermanson O. Ceccatelli S. (2006) High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J. Neurochem. 97, 69 78.
51. Thomas D. J. Smith J. C. (1982) Effects of coadministered low-molecular-weight thiol compounds on short-term distribution of methyl mercury in the rat. Toxicol. Appl. Pharmacol. 62, 104 110.
52. Uchino H., Kanai Y., Kim D. K., Wempe M. F., Chairoungdua A., Morimoto E., Anders M. W. Endou H. (2002) Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol. Pharmacol. 61, 729 737.
53. Verrey F. (2003) System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 445, 529 533.
54. Watanabe C., Yoshida K., Kasanuma Y., Kun Y. Satoh H. (1999) In utero methylmercury exposure differentially affects the activities of selenoenzymes in the fetal mouse brain. Environ. Res. 80, 208 214.
55. WHO: World Health Organization 2000) Mercury. Air quality guidelines, 2nd edn. WHO Regional Office for Europe, Copenhagen, Denmark. Chap. 6.9.
56. Yanagida O., Kanai Y., Chairoungdua A. et al. (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta 1514, 291 302.